MR [Mindray Medical International] UPLOAD:
[]
MR [Mindray Medical International] CORRESP: (Original Filing)
[June 18, 2012 Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Comment Letter 2011 Form 20-F Commission On behalf of Mindray Medical International Limited (the Staff]
MR [Mindray Medical International] CORRESP: June 18, 2012 Mr. Martin James Senior Assistant
[June 18, 2012 Mr. Martin James Senior Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr. James: Company Comment Letter 2011 Form 20-F Commission On behalf of Mindray Medical International Limited (the Staff]
MR [Mindray Medical International] CORRESP: (Original Filing)
[June18, 2012 Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December31, 2011 Filed April30, 2012 File No.001-33036 Dear Mr.James:mpanymment Letter 2011 Form 20-Fmmission On behalf of Mindray Medical International Limited (the]
MR [Mindray Medical International] CORRESP: June18, 2012 Mr.Martin James Seniorsistant Chief Accountant Division
[June18, 2012 Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December31, 2011 Filed April30, 2012 File No.001-33036 Dear Mr.James:mpanymment Letter 2011 Form 20-Fmmission On behalf of Mindray Medical International Limited (the]
MR [Mindray Medical International] CORRESP: Confidential Treatment Requested By Mindray Medical International Limitednfidential
[Confidential Treatment Requested By Mindray Medical International Limitednfidential Informationnfidential Material In accordance with Rule 83, this Letter hasso been clearly marked with the legendnfidential Treatment Requested by Mindray Medical International Limited and each page is marked for the record with the identifying numbers andde M-1 through M-9.]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Medical to Acquire Controlling Stake in Dragonbios Orthopedics Business for US$35.5 million SHENZHEN, China, June 6, 2012 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire a controlling stake of Wuhan Dragonbio Surgical Implant Co., Ltd. (Dragonbio), a domestic medical orthopedic products provider that]
MR [Mindray Medical International] 6-K: Mindray Medical to Acquire Controlling Stake in Dragonbios
[Mindray Medical to Acquire Controlling Stake in Dragonbios Orthopedics Business for US$35.5 million SHENZHEN, China, June 6, 2012 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire a controlling stake of Wuhan Dragonbio Surgical Implant Co., Ltd. (Dragonbio), a domestic medical orthopedic products provider that]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Medical to Acquirentrolling Stake in Dragonbios Orthopedics Business for US$35.5 million STYLE="font-family:Times New Roman" SIZE="2"> STYLE="font-family:Times New Roman" SIZE="2">SHENZHEN, China, June6, 2012 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitivereement to acquire antrolling stake of Wuhan Dragonbio Surgical Implant (Dragonbio), a domestic]
MR [Mindray Medical International] 6-K: Mindray Medical to Acquirentrolling Stake in Dragonbios Orthopedics
[Mindray Medical to Acquirentrolling Stake in Dragonbios Orthopedics Business for US$35.5 million STYLE="font-family:Times New Roman" SIZE="2"> STYLE="font-family:Times New Roman" SIZE="2">SHENZHEN, China, June6, 2012 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitivereement to acquire antrolling stake of Wuhan Dragonbio Surgical Implant (Dragonbio), a domestic]
